TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Infection Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Infection Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Infection Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Infection Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Infection Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Infection Drugs industry

Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
"Chimeric Molecules And Uses Thereof"THE UNIVERSITY OF QUEENSLANDMay 14, 2025JAMES POOLE
Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER
Antibacterial Antifungal CompositionADEKAApr 15, 2025BEIERSDORF
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025SOCIETE DES PRODUITS NESTLE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Moisturizing Antibacterial CompositionUNILEVERMar 13, 2025HENKEL
Antiviral Pharmaceutical Composition Comprising At Least One Sulphate PolysaccharideMARINOMED BIOTECHJan 17, 2025HAMPTON KNOWLES
Methods Of Treating Bacterial InfectionsMELINTA THERAPEUTICSDec 20, 2024GENERICS UK
Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024ZENTIVA KS

To stay ahead in the competitive Infection Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Infection Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS5
Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA5
Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE4
Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-CyclodextrinMERCK SHARP & DOHME4
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE4
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3
Jan 8, 2020Modulators Of Pharmacokinetic Properties Of TherapeuticsGILEAD SCIENCES3
Dec 13, 2017Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayEMORY UNIVERSITY3